BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 9227750)

  • 1. Field study of the safety, immunogenicity, and efficacy of an inactivated equine rotavirus vaccine.
    Powell DG; Dwyer RM; Traub-Dargatz JL; Fulker RH; Whalen JW; Srinivasappa J; Acree WM; Chu HJ
    J Am Vet Med Assoc; 1997 Jul; 211(2):193-8. PubMed ID: 9227750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of rotavirus diarrhoea in foals by parenteral vaccination of the mares: field trial.
    Barrandeguy M; Parreño V; Lagos Mármol M; Pont Lezica F; Rivas C; Valle C; Fernandez F
    Dev Biol Stand; 1998; 92():253-7. PubMed ID: 9580371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Equine vaccine for West Nile virus.
    Ng T; Hathaway D; Jennings N; Champ D; Chiang YW; Chu HJ
    Dev Biol (Basel); 2003; 114():221-7. PubMed ID: 14677692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The protection of newborn calves against experimental rotavirus infection by feeding mammary secretions from vaccinated cows.
    Castrucci G; Frigeri F; Ferrari M; Aldrovandi V; Tassini F; Gatti R
    Microbiologica; 1988 Oct; 11(4):379-85. PubMed ID: 2851089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of a chemically inactivated, adjuvanted vaccine to control abortigenic infection of mares by equine herpesvirus I.
    Bryans JT; Allen GP
    Dev Biol Stand; 1982; 52():493-8. PubMed ID: 6299858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunity and the level of neutralization antibodies in foals and mares vaccinated with a modified live-virus rhinopneumonitis vaccine.
    Dutta SK; Shipley WD
    Am J Vet Res; 1975 Apr; 36(4 Pt.1):445-8. PubMed ID: 164808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity, safety and efficacy of tetravalent rhesus-human, reassortant rotavirus vaccine in Belém, Brazil.
    Linhares AC; Gabbay YB; Mascarenhas JD; de Freitas RB; Oliveira CS; Bellesi N; Monteiro TA; Lins-Lainson Z; Ramos FL; Valente SA
    Bull World Health Organ; 1996; 74(5):491-500. PubMed ID: 9002329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of a commercial vaccine for preventing disease caused by influenza virus infection in horses.
    Morley PS; Townsend HG; Bogdan JR; Haines DM
    J Am Vet Med Assoc; 1999 Jul; 215(1):61-6. PubMed ID: 10397067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune response of pregnant cows to bovine rotavirus immunization.
    Saif LJ; Smith KL; Landmeier BJ; Bohl EH; Theil KW; Todhunter DA
    Am J Vet Res; 1984 Jan; 45(1):49-58. PubMed ID: 6322624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the South African asinine-94 strain of equine arteritis virus (EAV) in pregnant donkey mares and duration of maternal immunity in foals.
    Paweska JT
    Onderstepoort J Vet Res; 1997 Jun; 64(2):147-52. PubMed ID: 9352564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Foal IgG and opsonizing anti-Rhodococcus equi antibodies after immunization of pregnant mares with a protective VapA candidate vaccine.
    Cauchard J; Sevin C; Ballet JJ; Taouji S
    Vet Microbiol; 2004 Nov; 104(1-2):73-81. PubMed ID: 15530741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum antibody responses to equine herpesvirus 1 glycoprotein D in horses, pregnant mares and young foals.
    Foote CE; Love DN; Gilkerson JR; Rota J; Trevor-Jones P; Ruitenberg KM; Wellington JE; Whalley JM
    Vet Immunol Immunopathol; 2005 May; 105(1-2):47-57. PubMed ID: 15797474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of a mutagen-attenuated Rift Valley fever virus vaccine in fetal and neonatal bovids.
    Morrill JC; Mebus CA; Peters CJ
    Am J Vet Res; 1997 Oct; 58(10):1110-4. PubMed ID: 9328663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of calf diarrhoea vaccines.
    Snodgrass DR
    Ann Rech Vet; 1983; 14(4):519-21. PubMed ID: 6329064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The first safe inactivated equine influenza vaccine formulation adjuvanted with ISCOM-Matrix that closes the immunity gap.
    Heldens JG; Pouwels HG; Derks CG; Van de Zande SM; Hoeijmakers MJ
    Vaccine; 2009 Sep; 27(40):5530-7. PubMed ID: 19607950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there a benefit from an early booster vaccination in the control of equine influenza?
    Heldens JG; van Loon AA; van de Zande S
    Vet J; 2007 Nov; 174(3):592-8. PubMed ID: 17560150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against naturally acquired Rhodococcus equi pneumonia in foals by administration of hyperimmune plasma.
    Madigan JE; Hietala S; Muller N
    J Reprod Fertil Suppl; 1991; 44():571-8. PubMed ID: 1795301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination of pregnant ponies against equine rhinopneumonitis.
    Crandell RA; Mock RE; Lock TF
    Am J Vet Res; 1980 Jul; 41(7):994-6. PubMed ID: 6254412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonatal administration of rhesus rotavirus tetravalent vaccine.
    Vesikari T; Karvonen A; Forrest BD; Hoshino Y; Chanock RM; Kapikian AZ
    Pediatr Infect Dis J; 2006 Feb; 25(2):118-22. PubMed ID: 16462287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Passive transfer, rate of decay, and protein specificity of antibodies against equine arteritis virus in horses from a Standardbred herd with high seroprevalence.
    Hullinger PJ; Wilson WD; Rossitto PV; Patton JF; Thurmond MC; MacLachlan NJ
    J Am Vet Med Assoc; 1998 Sep; 213(6):839-42. PubMed ID: 9743724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.